|
OBJECTIVES
●
Highlight
scientific progress on drug discovery programs aimed at
treating Alzheimer’s disease and related dementias.
●
Increase
networking opportunities for scientists to share
information and resources.
●
Foster
interdisciplinary and public-private partnerships and
alliances.
|
TARGET
AUDIENCE
The 2012
edition of this conference
attracted attendees
from around the world.
Attendees included:
●
Academic and industry
scientists engaged in
drug discovery research
for neurodegenerative
diseases and CNS
●
Business development
and licensing
professionals
●
Alliance management
professionals
●
Venture capitalists
and other investors |